Boryung Corporation (KRX:003850)

Market Cap	849.03B +21.0%
Revenue (ttm)	1.02T +0.0%
Net Income	64.30B -7.7%
EPS	765.85 -24.6%
Shares Out	84.48M
PE Ratio	13.12
Forward PE	22.43
Dividend	100.00 (1.00%)
Ex-Dividend Date	Dec 29, 2025

Volume	103,146
Average Volume	189,605
Open	10,010
Previous Close	9,980
Day's Range	9,960 - 10,090
52-Week Range	8,080 - 10,800
Beta	0.35
RSI	56.19
Earnings Date	May 15, 2026

About Boryung

Boryung Corporation engages in the manufacture and sale of pharmaceutical products in South Korea and internationally. It offers prescription drugs for hypertension, dyslipidemia, and diabetes drugs. The company was formerly known as Boryung Pharmaceutical Co., Ltd. and changed its name to Boryung Corporation in March 2022. Boryung Corporation was founded in 1957 and is headquartered in Seoul, South Korea.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1957
• Employees: 1,533
• Stock Exchange: Korea Stock Exchange
• Ticker Symbol: 003850

Financial Performance

In 2025, Boryung's revenue was 1.02 trillion, an increase of 0.03% compared to the previous year's 1.02 trillion. Earnings were 64.30 billion, a decrease of -7.65%.